The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF seeks to replicate as closely as possible the price and yield performance of the CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index and invests in a portfolio comprised primarily of Chinese healthcare companies
The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in China. The Tibet Eastmoney Funds fund’s base currency is CNY and the share class was registered 21.04.2023 with unique ISIN - CNE100005YZ1. Main exchange is Shenzhen SE and ticker symbol is 159622. The total expense ratio is 0.55%. The Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry ETF (CNY) pays dividends 1 time(s) per year.